journal article·2012-03

Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles

Tianlong Liu, Linlin Li, Changhui Fu, Huiyu Liu, Dong Chen, Fangqiong Tang

Biomaterials· Volume 33· Issue 7
Publisher page

Abstract

Crystalline silica is well known to induce chronic lung inflammation by inhalation that can progress to silicosis. Recently, we reported that silica nanoparticles (SN) cause more damage to liver instead of lung when they enter the body by intravenous injection. However, this mechanism is still unclear. In the present study, liver damages caused by mesoporous hollow silica nanoparticles (MHSNs) were demonstrated after continuous intraperitoneal injection into mice twice a week for 6 weeks. The administration of MHSNs at 50 mg/kg increased liver injury markers in serum, such as alanine aminotransferase (ALT), inflammatory cytokines interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α). Histological analysis revealed lymphocytic infiltration and silicotic nodular like lesions in liver. Collagen fibers were observed around the silicotic nodular like lesion, and hydroxyproline level in liver was also increased dramatically. We also found that activated kupffer cells (KCs) played a key role in the liver damage caused by SNs similar to alveolar macrophage in the process of silicosis. These suggest that the mechanism of liver damage caused by SNs is in consonance with the occurrence of silicosis. These findings may provide useful information for the further toxicity and bioapplication research of nanoparticles.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Occupational and environmental lung diseases · Phagocytosis and Immune Regulation · Liver physiology and pathology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (55)

Show source-provided references
1. Mesoporous silicate materials as substrates for molecular machines and drug delivery10.1016/j.cej.2007.07.074 ↗
2. General strategy for designing functionalized magnetic microspheres for different bioapplications10.1021/la901258p ↗
3. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function10.1016/j.biomaterials.2009.09.060 ↗
4. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness10.1139/jpn.090083 ↗
5. The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species10.1016/j.biomaterials.2010.04.055 ↗
6. Silica binding and toxicity in alveolar macrophages10.1016/j.freeradbiomed.2007.12.027 ↗
7. Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolized amorphous silica nanoparticles10.3109/08958370903359992 ↗
8. Detection of silica particles in lung tissue by environmental scanning electron microscopy10.1080/08958370802294647 ↗
9. Risk of silicosis in cohorts of Chinese tin and tungsten miners and pottery workers (II): workplace-specific silica particle surface composition10.1002/ajim.20175 ↗
10. Respirable crystalline silica exposure-response evaluation of silicosis morbidity and lung cancer mortality in the German porcelain industry cohort10.1097/JOM.0b013e31820c2bff ↗
11. Silica exposure and silicosis: action is needed now10.1097/SMJ.0b013e3181f6822f ↗
12. Mesoscale porous silica as drug delivery vehicles: synthesis, characterization, and pH-sensitive release profiles10.1016/j.micromeso.2010.10.035 ↗
13. Preparation of pH-responsive mesoporous silica nanoparticles and their application in controlled drug delivery10.1021/jp201053d ↗
14. Uniform hollow mesoporous silica nanocages for drug delivery in vitro and in vivo for liver cancer therapy10.1039/c0jm04115g ↗
15. Nanomedicine and nanotoxicology: two sides of the same coin10.1016/j.nano.2005.10.003 ↗
16. Nanotoxicology and nanomedicine: making hard decisions10.1016/j.nano.2008.01.001 ↗
17. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology10.1111/j.1365-2796.2009.02187.x ↗
18. Biological barriers–a need for novel tools in nanotoxicology and nanomedicine10.1016/j.ejpb.2011.02.006 ↗
19. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice10.1007/s00204-009-0488-x ↗
20. Influence of 70 nm silica particles in mice with cisplatin or paraquat-induced toxicity
21. Histological analysis of 70-nm silica particles-induced chronic toxicity in mice10.1016/j.ejpb.2009.03.007 ↗
22. Facile and scalable synthesis of tailored silica nanorattle structures10.1002/adma.200900599 ↗
23. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy10.1021/nn100918a ↗
24. Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity10.1002/anie.201002820 ↗
25. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice10.1016/j.biomaterials.2010.10.035 ↗
26. Silica, silicosis and tuberculosis
27. Mortality from non-malignant respiratory diseases among people with silicosis in Hong Kong: exposure-response analyses for exposure to silica dust10.1136/oem.2006.028506 ↗
28. Genetic polymorphisms in alveolar macrophage response-related genes, and risk of silicosis and pulmonary tuberculosis in Chinese iron miners10.1016/j.ijheh.2006.11.010 ↗
29. Regulation of lung fibroblast proliferation and collagen-synthesis by alveolar macrophages in experimental silicosis. 1:Effect of macrophage conditioned medium from silica instilled rats
30. Systemic macrophage stimulation in rats with silicosis - enhanced release of tumor-necrosis-factor-alpha from alveolar and peritoneal-macrophages10.1165/ajrcmb/5.4.395 ↗
31. Superoxide anion release by alveolar macrophage subpopulations in experimental silicosis
32. Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis10.1093/toxsci/kfl173 ↗
33. Kupffer cell activation is a causal factor for hepatic insulin resistance
34. Upregulation of Kupffer cell alpha(2A)-Adrenoceptors and downregulation of MKP-1 mediate hepatic injury in chronic alcohol exposure10.1016/j.bbrc.2011.05.007 ↗
35. Kupffer cell depletion reduces hepatic inflammation and apoptosis but decreases survival in abdominal sepsis10.1097/MEG.0b013e32833847db ↗
36. Kupffer cells prevent cell death of activated hepatic stellate cells through Il1 beta-mediated Nf-Kappa B activation
37. Kupffer cell targeted delivery of nfkb decoy suppress hepatic ishchemia/reperfusion injury
38. Loss of Sept4 exacerbates liver fibrosis through the dysregulation of hepatic stellate cells10.1016/j.jhep.2008.05.026 ↗
39. Improved determination of small amounts of free hydroxyproline in biological fluids10.1093/clinchem/40.9.1735 ↗
40. MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice10.1074/jbc.M605229200 ↗
41. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers10.1016/j.addr.2008.03.012 ↗
42. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells10.1002/smll.200800926 ↗
43. Mesoporous silica nanoparticles inhibit cellular respiration10.1021/nl080250u ↗
44. Ultrasmall, well-dispersed, hollow siliceous spheres with enhanced endocytosis properties10.1002/smll.200901631 ↗
45. Novel drug delivery system of hollow mesoporous silica nanocapsules with thin shells: preparation and fluorescein isothiocyanate (FITC) release kinetics10.1016/j.colsurfb.2007.03.005 ↗
46. Silica nanoparticles as hepatotoxicants10.1016/j.ejpb.2009.02.005 ↗
47. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis10.1016/j.lfs.2010.06.016 ↗
48. Basic pathogenetic mechanisms in silicosis: current understanding10.1097/01.mcp.0000152998.11335.24 ↗
49. Dependence of NF-kappaB activation and free radical generation on silica-induced TNF-alpha production in macrophages10.1023/A:1007051402840 ↗
50. The sources of inflammatory mediators in the lung after silica exposure10.1289/ehp.7295 ↗
51. The effect of surface modification of amorphous silica particles on NLRP3 inflammasome mediated IL-1beta production, ROS production and endosomal rupture10.1016/j.biomaterials.2010.05.036 ↗
52. Activation of the IL-1 beta-processing inflammasome is involved in contact hypersensitivity10.1038/sj.jid.5700819 ↗
53. Reactive oxygen species-independent activation of the IL-1beta inflammasome in cells from patients with chronic granulomatous disease10.1073/pnas.0914795107 ↗
54. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis10.1177/039139880903201206 ↗
55. Zinc: role in immunity, oxidative stress and chronic inflammation